% alzhub.org library filter
% Source: https://alzhub.org/research?author=Boada+M&institution=I4210086696
% 7 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{florian2023-36730056,
  author  = {Florian, H. and Wang, D. and Arnold, S. E. and Boada, M. and Guo, Q. and Jin, Z. and Zheng, H. and Fisseha, N. and others},
  title   = {{Tilavonemab in early Alzheimer's disease: results from a phase 2, randomized, double-blind study}},
  journal = {Brain : a journal of neurology},
  year    = {2023},
  doi     = {10.1093/brain/awad024},
  pmid    = {36730056},
  url     = {https://doi.org/10.1093/brain/awad024}
}

@article{boada2020-32715623,
  author  = {Boada, M. and López, O. L. and Olazarán, J. and Núñez, L. and Pfeffer, M. and Paricio, M. and Lorites, J. and Piñol-Ripoll, G. and others},
  title   = {{A randomized, controlled clinical trial of plasma exchange with albumin replacement for Alzheimer's disease: Primary results of the AMBAR Study}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2020},
  doi     = {10.1002/alz.12137},
  pmid    = {32715623},
  url     = {https://doi.org/10.1002/alz.12137}
}

@article{gomezisla2008-18317243,
  author  = {Gómez-Isla, T. and Blesa, R. and Boada, M. and Clarimón, J. and Del Ser, T. and Domenech, G. and Ferro, J. M. and Gómez-Ansón, B. and others},
  title   = {{A randomized, double-blind, placebo controlled-trial of triflusal in mild cognitive impairment: the TRIMCI study}},
  journal = {Alzheimer disease and associated disorders},
  year    = {2008},
  doi     = {10.1097/wad.0b013e3181611024},
  pmid    = {18317243},
  url     = {https://doi.org/10.1097/wad.0b013e3181611024}
}

@article{li2023-37260021,
  author  = {Li, D. and Farrell, J. J. and Mez, J. and Martin, E. R. and Bush, W. S. and Ruiz, A. and Boada, M. and de Rojas, I. and Mayeux, R. and Haines, J. L. and Vance, M. A. P. and Wang, L. S. and others},
  title   = {{Novel loci for Alzheimer's disease identified by a genome-wide association study in Ashkenazi Jews}},
  journal = {Alzheimer's \& Dementia},
  year    = {2023},
  doi     = {10.1002/alz.13117},
  pmid    = {37260021},
  url     = {https://doi.org/10.1002/alz.13117}
}

@article{ahmad2024-39080778,
  author  = {Ahmad, S. and Yang, W. and Orellana, A. and Frölich, L. and de Rojas, I. and Cano, A. and Boada, M. and Hernández, I. and others},
  title   = {{Association of oxidative stress and inflammatory metabolites with Alzheimer's disease cerebrospinal fluid biomarkers in mild cognitive impairment}},
  journal = {Alzheimer's research \& therapy},
  year    = {2024},
  doi     = {10.1186/s13195-024-01542-4},
  pmid    = {39080778},
  url     = {https://doi.org/10.1186/s13195-024-01542-4}
}

@article{franzmeier2021-30899092,
  author  = {Franzmeier, N. and Ren, J. and Damm, A. and Monté-Rubio, G. and Boada, M. and Ruiz, A. and Ramirez, A. and Jessen, F. and others},
  title   = {{The BDNFVal66Met SNP modulates the association between beta-amyloid and hippocampal disconnection in Alzheimer's disease}},
  journal = {Molecular psychiatry},
  year    = {2021},
  doi     = {10.1038/s41380-019-0404-6},
  pmid    = {30899092},
  url     = {https://doi.org/10.1038/s41380-019-0404-6}
}

@article{morato2022-36012569,
  author  = {Morató, X. and Pytel, V. and Jofresa, S. and Ruiz, A. and Boada, M.},
  title   = {{Symptomatic and Disease-Modifying Therapy Pipeline for Alzheimer's Disease: Towards a Personalized Polypharmacology Patient-Centered Approach}},
  journal = {International journal of molecular sciences},
  year    = {2022},
  doi     = {10.3390/ijms23169305},
  pmid    = {36012569},
  url     = {https://doi.org/10.3390/ijms23169305}
}